|
1
|
Avery A: Molecular diagnostics of
hematologic malignancies. Top Companion Anim Med. 24:144–150. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nowell PC and Hungerford DA: Chromosome
studies in human leukemia. IV Myeloproliferative syndrome and other
atypical myeloid disorders. J Natl Cancer Inst. 29:911–931.
1962.PubMed/NCBI
|
|
3
|
Chen Y, Peng C, Li D and Li S: Molecular
and cellular bases of chronic myeloid leukemia. Protein Cell.
1:124–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laurent E, Talpaz M, Kantarjian H and
Kurzrock R: The BCR gene and philadelphia chromosome-positive
leukemogenesis. Cancer Res. 61:2343–2355. 2001.PubMed/NCBI
|
|
5
|
Kurzrock R, Kantarjian HM, Druker BJ and
Talpaz M: Philadelphia chromosome-positive leukemias: from basic
mechanisms to molecular therapeutics. Ann Intern Med. 138:819–830.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Melo JV: The diversity of BCR-ABL fusion
proteins and their relationship to leukemia phenotype. Blood.
88:2375–2384. 1996.PubMed/NCBI
|
|
7
|
Pane F, Frigeri F, Sindona M, Luciano L,
Ferrara F, Cimino R, Meloni G, Saglio G, Salvatore F and Rotoli B:
Neutrophilic-chronic myeloid leukemia: a distinct disease with a
specific molecular marker (BCR/ABL with C3/A2 junction). Blood.
88:2410–2414. 1996.PubMed/NCBI
|
|
8
|
Groffen J, Stephenson JR, Heisterkamp N,
de Klein A, Bartram CR and Grosveld G: Philadelphia chromosomal
breakpoints are clustered within a limited region, bcr, on
chromosome 22. Cell. 36:93–99. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Heisterkamp N, Knoppel E and Groffen J:
The first BCR gene intron contains breakpoints in Philadelphia
chromosome positive leukemia. Nucleic Acids Res. 16:10069–10081.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shtivelman E, Lifshitz B, Gale RP, Roe BA
and Canaani E: Alternative splicing of RNAs transcribed from the
human abl gene and from the bcr-abl fused gene. Cell. 47:277–284.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Woodring PJ, Hunter T and Wang JY:
Regulation of F-actin-dependent processes by the Abl family of
tyrosine kinases. J Cell Sci. 116:2613–2626. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li S, Couvillon AD, Brasher BB and Van
Etten RA: Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal
growth factor receptor: a novel regulatory mechanism for tyrosine
kinase signaling. EMBO J. 20:6793–6804. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rumpold H and Webersinke G: Molecular
pathogenesis of philadelphia-positive chronic myeloid leukemia - is
it all BCR-ABL? Curr Cancer Drug Targets. 11:3–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Janz S, Potter M and Rabkin CS: Lymphoma-
and leukemia-associated chromosomal translocations in healthy
individuals. Genes Chromosomes Cancer. 36:211–223. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song J, Mercer D, Hu X, Liu H and Li MM:
Common leukemia- and lymphoma-associated genetic aberrations in
healthy individuals. J Mol Diagn. 13:213–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cross NC, Melo JV, Feng L and Goldman JM:
An optimized multiplex polymerase chain reaction (PCR) for
detection of BCR-ABL fusion mRNAs in haematological disorders.
Leukemia. 8:186–189. 1994.PubMed/NCBI
|
|
17
|
Nogva HK, Evensen SA and Madshus IH:
One-tube multiplex RT-PCR of BCR-ABL transcripts in analysis of
patients with chronic myeloid leukaemia and acute lymphoblastic
leukaemia. Scand J Clin Lab Invest. 58:647–654. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaneda R, Toyota M, Yamashita Y, Koinuma
K, Choi YL, Ota J, Kisanuki H, Ishikawa M, Takada S, Shimada K and
Mano H: High-throughput screening of genome fragments bound to
differentially acetylated histones. Genes Cells. 9:1167–1174. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okamoto K, Karasawa M, Sakai H, Ogura H,
Morita K and Naruse T: A novel acute lymphoid leukemia type BCR/ABL
transcript in chronic myelogenous leukemia. Br J Haematol.
96:611–613. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lichty B, Keating A, Callum J, Yee K,
Croxford R, Corpus G, Nwachukwu B, Kim P, Guo J and Kamel-Reid S:
Expression of p210 and p190 BCR-ABL due to alternative splicing in
chronic myelogenous leukemia. Br J Haematol. 103:711–715. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Biernaux C, Loos M, Sels A, Huez G and
Stryckmans P: Detection of major bcr-abl gene expression at a very
low level in blood cells of some healthy individuals. Blood.
86:3118–3122. 1995.PubMed/NCBI
|
|
22
|
Bose S, Deininger M, Gora-Tybor J, Goldman
JM and Melo JV: The presence of typical and atypical BCR-ABL fusion
genes in leukocytes of normal individuals: biologic significance
and implications for the assessment of minimal residual disease.
Blood. 92:3362–3367. 1998.
|
|
23
|
Daley GQ, Van Etten RA and Baltimore D:
Induction of chronic myelogenous leukemia in mice by the
P210bcr/abl gene of the Philadelphia chromosome. Science.
247:824–830. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kelliher MA, McLaughlin J, Witte ON and
Rosenberg N: Induction of a chronic myelogenous leukemia-like
syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA.
87:6649–6653. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Elefanty AG and Cory S: Hematologic
disease induced in BALB/c mice by a bcr-abl retrovirus is
influenced by the infection conditions. Mol Cell Biol.
12:1755–1763. 1992.PubMed/NCBI
|
|
26
|
Bäsecke J, Griesinger F, Trümper L and
Brittinger G: Leukemia- and lymphoma-associated genetic aberrations
in healthy individuals. Ann Hematol. 81:64–75. 2002.
|
|
27
|
Ren R: Mechanisms of BCR-ABL in the
pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer.
5:172–183. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rusakiewicz S, Madrigal A, Travers P and
Dodi AI: BCR/ABL- specific CD8+ T cells can be detected
from CML patients, but are only expanded from healthy donors.
Cancer Immunol Immunother. 58:1449–1457. 2009.PubMed/NCBI
|
|
29
|
Posthuma EF, Falkenburg JH, Apperley JF,
Gratwohl A, Roosnek E, Hertenstein B, Schipper RF, Schreuder GM,
D’Amaro J, Oudshoorn M, et al: HLA-B8 and HLA-A3 coexpressed with
HLA-B8 are associated with a reduced risk of the development of
chronic myeloid leukemia. The Chronic Leukemia Working Party of the
EBMT. Blood. 93:3863–3865. 1999.PubMed/NCBI
|
